COVAX is the Corona Virus Vaccine Alliance of rich countries, WHO and other world organizations. COVAX is led by Gavi.
COVAX the vaccine alliance aims to act as a platform that will support the research, development and manufacturing of a wide range of COVID-19 vaccine candidates, and negotiate their pricing.
All participating countries, regardless of income levels, will have equal access to these vaccines once they are developed.
The initial aim is to have 2 billion doses available by the end of 2021, which should be enough to protect high risk and vulnerable people, as well as frontline healthcare workers.